MedPath

NAZOPHYL DARVA

NAZOPHYL DARVA

Discontinued
DIN Number

00166375

Drug Class

Human

Market Date

Dec 31, 1930

Company
HC

produits francais labs inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00166375
AIG Number0701135001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R05X OTHER COLD PREPARATIONS
Product Specifications
Dosage FormOintment
Route of AdministrationNasal
AHFS Classification48:01.00*
Health Canada Classification

ACTIVE INGREDIENTS (7)

CAMPHORActive
Strength: 247 MG / 30 G
Monograph: CAMPHOR
EUCALYPTOLActive
Strength: .066 ML / 30 G
Monograph: EUCALYPTOL
MENTHOLActive
Strength: 177.45 MG / 30 G
Monograph: MENTHOL
METHYL SALICYLATEActive
Strength: .0195 ML / 30 G
Monograph: METHYL SALICYLATE
METHYLENE BLUEActive
Strength: .1014 MG / 30 G
Monograph: METHYLENE BLUE
OIL OF CAJEPUTActive
Strength: .039 ML / 30 G
Monograph: OIL OF CAJEPUT
THYMOLActive
Strength: 27.95 MG / 30 G
Monograph: THYMOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.